# Adjunctive Cannabidiol for Recovery From Opioid Study

> **NCT06940674** · PHASE3 · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 450 (estimated)

## Conditions studied

- Opioid Use Disorder (OUD)

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06940674
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-13
- **Primary completion:** 2027-07-15
- **Final completion:** 2027-08-15
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06940674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06940674, "Adjunctive Cannabidiol for Recovery From Opioid Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06940674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*